Qube Research & Technologies LTD Synlogic, Inc. Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$2.2 - $5.05 $24,483 - $56,201
-11,129 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$1.85 - $2.54 $20,588 - $28,267
11,129 New
11,129 $24,000
Q3 2020

Nov 12, 2020
SELL
$1.85 - $2.57 $30,162 - $41,901
-16,304 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.59 - $2.51 $25,923 - $40,923
16,304 New
16,304 $33,000

Others Institutions Holding SYBX

# of Institutions
2
Shares Held
25.5K
Call Options Held
0
Put Options Held
0
View Full List

About SYNLOGIC, INC.

SYBX Quotes by TradingView
  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email